Microfluidic Cartridge Mixing for Rapid Nucleic Acid Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nucleic acid extraction and detection methods require specialized equipment, large sample volumes, long incubation times, and skilled personnel, and are limited by diffusion constraints, making them inefficient and labor-intensive.
Innovation Solution
A removable cartridge system with a microfluidic assembly, vibration-driven mixing, and a nucleic acid-detecting microarray module, integrated with a battery-powered, fieldable system for automated sample preparation and detection, enabling efficient extraction and detection of nucleic acids in smaller volumes with enhanced transport and sensitivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional nucleic acid extraction and detection methods are used in laboratory settings, then detection sensitivity and accuracy are improved, but device complexity and requirement for trained personnel increase
Solution Approach 1:
The patent combines multiple separate laboratory functions (sample lysis, nucleic acid extraction, purification, and detection) into a single integrated microfluidic cartridge system. The microfluidic assembly integrates reagent reservoirs, mixing chambers, extraction matrices, and detection arrays into one unified device that performs the entire workflow from sample input to result output without requiring separate equipment for each step.
Solution Approach 2:
The system employs automated fluid handling with pumps and valves that automatically transport samples and reagents through the microfluidic channels without manual intervention. The vibration motor automatically mixes samples with reagents, and the heated chamber automatically performs thermal cycling for nucleic acid amplification, eliminating the need for trained personnel to perform manual laboratory techniques.
2Measurement precision
If large sample volumes are used to ensure sufficient nucleic acid targets, then detection sensitivity is improved, but the volume of biological material required increases
Solution Approach 1:
The patent uses a porous extraction matrix within the microfluidic cartridge that provides a large surface area for nucleic acid binding. This porous structure allows efficient capture and concentration of nucleic acid targets from small sample volumes, enabling sufficient detection sensitivity without requiring large amounts of biological material.
Solution Approach 2:
The system employs concentrated reagent formulations and optimized buffer compositions that enhance nucleic acid binding efficiency and signal amplification. By changing the chemical parameters of the extraction and detection reagents, the system achieves high sensitivity with minimal sample input.
3Ease of operation
If manual processing steps are used for sample lysis and nucleic acid extraction, then ease of operation is reduced, but processing control and reliability are improved
Solution Approach 1:
The patent replaces manual mechanical operations (pipetting, vortex mixing, centrifugation) with automated microfluidic mechanisms. Miniature pumps and valves control fluid flow through the cartridge, a vibration motor provides mixing, and a heated chamber performs thermal processing, all controlled by a microprocessor that ensures consistent, reproducible results without manual intervention.
Solution Approach 2:
The microprocessor-controlled fluid switching assembly acts as an intermediary that automatically directs sample and reagent flow through different chambers and channels based on the processing stage. This automated flow control ensures that each step of the nucleic acid extraction and detection process occurs in the correct sequence with precise timing, maintaining reliability while eliminating manual operations.
4Measurement precision
If long incubation durations are used for nucleic acid amplification and detection, then detection sensitivity is improved, but the time required for results increases
Solution Approach 1:
The patent employs periodic thermal cycling through a heated chamber that rapidly alternates between different temperatures to facilitate nucleic acid amplification. This periodic heating and cooling cycle, controlled by a microprocessor, enables efficient DNA amplification in a shortened time frame while maintaining detection sensitivity through multiple amplification cycles.
Solution Approach 2:
The system uses a vibration motor to agitate and mix samples during incubation periods, enhancing the rate of molecular interactions between nucleic acids and probes. This mechanical vibration increases the efficiency of binding and amplification reactions, reducing the required incubation time while preserving detection sensitivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system allows minimally-trained users to perform all-in-one sample-to-answer nucleic acid extraction and detection, achieving high yield and sensitivity with reduced sample volumes and incubation times, suitable for field applications.
Implementation Method 1
vibration-driven mixing agitates fluids while present in the assay chamber
Implementation Method 2
nucleic acid-detecting microarray module positioned in the assay chamber
Data Source
AI summary
A removable cartridge to be used in a system for extracting and detecting nucleic acids from heterogeneous samples includes a plurality of reservoirs defining at least a first wash buffer reservoir for holding a first wash buffer and a microfluidic assembly configured to attach to the plurality of reservoirs. The microfluidic assembly includes at least one sample reservoir and a nucleic acid extraction matrix in fluid communication to an automated sample preparation (ASP) reservoir through a first flow channel defined by the microfluidic assembly. An assay chamber is in fluid communication with a third flow channel and with the waste reservoir through a fourth flow channel such that a labeled nucleic acid-containing sample flows through the assay chamber and then to the waste reservoir, wherein vibration-driven mixing agitates fluids while present in the assay chamber. Finally, a nucleic acid-detecting microarray module is positioned in the assay chamber.